ConductScience.org, home

Trial · NCT01656148

FAME - Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of Fampyra

NCT01656148, Phase 4, Completed, University of Southern Denmark

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. FAME - Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of Fampyra. Trials, record NCT01656148. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01656148

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
FAME - Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of Fampyra
NCT number
NCT01656148
Status
Completed
Phases
Phase 4
Enrollment
108 participants, actual
Lead sponsor
University of Southern Denmark
Conditions
Multiple Sclerosis
Interventions
Fampridine-SR
First posted
2012-08-02
Last updated
2018-08-23
Other registries' IDs
eudract:2011-006151-10

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryThe mean change in SSSTSSST is measured before and at the end of four weeks of treatmentSSST is measured before treatment with Fampridine-SR. Then again measured at day 26, 27 or 28 of four weeks of treatment with Fampridine-SR.
SecondaryMean change in T25FWFour weeksT25FW is measured before four weeks of treatment with Fampridine-SR and then on day 26, 27 or 28.
SecondaryMean change in hip flexion, knee flexion and knee extension forceFour weeksForce in the abovementioned areas is measured by dynamometry before four weeks of treatment with Fampridine-SR and on day 26, 27 or 28.
SecondaryMean change on Chair Rise TestFour weeksTime to rise from a chair five times is measured before four weeks of treatment with Fampridine-SR and on day 26, 27 or 28.
SecondaryMean change on 9-Hole Peg Test (9HPT)Four weeks9HPT is measured before four weeks of treatment with Fampridine-SR and on day 26, 27 or 28.
SecondaryMean change on Symbol Digit Modalitites Test (SDMT)Four weeksSDMT is measured before four weeks of treatment with Fampridine-SR and on day 26, 27 or 28.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers11

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
9109861BACKGROUNDPubMed
10355672BACKGROUNDPubMed
12804404BACKGROUNDPubMed
16472864BACKGROUNDPubMed
16900764BACKGROUNDPubMed
17439905BACKGROUNDPubMed
18672472BACKGROUNDPubMed
19249634BACKGROUNDPubMed
20976768BACKGROUNDPubMed
24852920DERIVEDPubMed

1 to 10 of 11

See all 11 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01656148

GET https://conductscience.org/api/trials/v1/NCT01656148/registered